Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Panchagnula

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|September 7, 2004
Transdermal iontophoresis of insulin: III. Influence of electronic parametersO Pillai, N Kumar, C S Dey, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 2006
Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinationsR Panchagnula, J Parmar, J K Kaur, et al.
International Journal of Pharmaceutics|May 5, 2001
Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skinR Panchagnula, P S Salve, N S Thomas, et al.
Current Opinion in Pulmonary Medicine|May 24, 2001
Antituberculosis drugs and new drug developmentS Agrawal, N S Thomas, A B Dhanikula, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 13, 2005
Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulationsS Agrawal, K J Kaur, I Singh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 29, 2005
Determination of rifampicin bioequivalence in a three-drug FDC by WHO and indian protocols: effect of sampling schedule and sizeS Agrawal, K J Kaur, I Singh, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 25, 2002
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulationsS Agrawal, I Singh, K J Kaur, et al.
Methods and Findings in Experimental and Clinical Pharmacology|August 4, 2001
Pharmacokinetic study of paclitaxel as a 3-hour infusion in an Indian population: 135 mg/m2 vs. 175 mg/m2A B Dhanikula, R Panchagnula, I Singh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 15, 2005
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatmentY Ashokraj, I Singh, K J Kaur, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinationsY Ashokraj, I Singh, K J Kaur, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Methods and Findings in Experimental and Clinical Pharmacology|September 7, 2004
Transdermal iontophoresis of insulin: III. Influence of electronic parametersO Pillai, N Kumar, C S Dey, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 2006
Plasma pooling to expedite bioequivalence estimation of rifampicin in fixed dose combinationsR Panchagnula, J Parmar, J K Kaur, et al.
International Journal of Pharmaceutics|May 5, 2001
Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skinR Panchagnula, P S Salve, N S Thomas, et al.
Current Opinion in Pulmonary Medicine|May 24, 2001
Antituberculosis drugs and new drug developmentS Agrawal, N S Thomas, A B Dhanikula, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 13, 2005
Minimum sample size and sampling time requirements for assessment of rifampicin bioequivalence from FDC formulationsS Agrawal, K J Kaur, I Singh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 29, 2005
Determination of rifampicin bioequivalence in a three-drug FDC by WHO and indian protocols: effect of sampling schedule and sizeS Agrawal, K J Kaur, I Singh, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 25, 2002
Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulationsS Agrawal, I Singh, K J Kaur, et al.
Methods and Findings in Experimental and Clinical Pharmacology|August 4, 2001
Pharmacokinetic study of paclitaxel as a 3-hour infusion in an Indian population: 135 mg/m2 vs. 175 mg/m2A B Dhanikula, R Panchagnula, I Singh, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 15, 2005
Establishment of a reference formulation for bioequivalence assessment of rifampicin-containing FDCs: an essential step towards improving tuberculosis treatmentY Ashokraj, I Singh, K J Kaur, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 24, 2005
Plasma pooling: utility in expediting bioequivalence assessment of rifampicin-containing fixed-dose combinationsY Ashokraj, I Singh, K J Kaur, et al.
Pageof 6